Abizer Gaslightwala - 03 Jan 2025 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Issuer symbol
AKTX
Transactions as of
03 Jan 2025
Net transactions value
+$1,032
Form type
4
Filing time
07 Jan 2025, 16:30:04 UTC
Previous filing
30 Dec 2024
Next filing
07 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX Ordinary Shares, par value $0.0001 per share Award $1,032 +1,720,000 +2.5% $0.000600 71,720,000 03 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares.
F2 On January 3, 2025, the Reporting Person acquired 1,720,000 Ordinary Shares at purchase prices ranging from of $0.00064 to $0.000625 per Ordinary Share.